|
|
Cephalon currently markets more than 20 products internationally, including six proprietary products in the United States. More than 24 percent of our sales comes from territories outside the United States.
As the company grows, we expand the reach and impact of Cephalon science, bringing new therapies for disorders of the central nervous system, pain, addiction and cancer to more patients and physicians. An increasing proportion of our business is international, and we continue to add regulatory, clinical, sales and marketing infrastructure needed to bring value to more and more locations around the globe. We’re only beginning to bring Cephalon therapeutic value to patients and physicians around the world.
|
|